Behavioral Economics Incentives for Health Management

Evaluation of Behavioral Economics Patient Incentive Strategies for Health Management

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01823458

Enrollment

152

Registered

2013-04-04

Start date

2012-04-30

Completion date

2014-08-31

Last updated

2017-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Type 2 Diabetes

Keywords

behavioral economics, incentives, health behavior, exercise

Brief summary

Incentives are increasingly being used to motivate health behavior in medical studies. Small cash payments conditional on certain health and welfare promoting behaviors have shown efficacy in both real world and experimental settings. Furthermore, in incentive studies, behavioral economics has been shown to amplify behavior change beyond what is possible with simple cash payments, but little is known about how varying incentive payment design may impact health behavior. The goal of the present study is to evaluate a new incentive payment instrument, lottery insurance, to determine its impact on adherence to the target health behavior, attendance at free exercise classes provided by QueensCare Family Clinics, a safety-net medical clinic.

Interventions

BEHAVIORALLottery Insurance

BEHAVIORALStandard Lottery

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 64 Years

Healthy volunteers

Inclusion criteria

* 18 to 64 years of age * BMI between 25-40 * Receiving care in QueensCare Family Clinics

Exclusion criteria

* Failure to obtain exercise clearance from physician

Design outcomes

Primary

Measure	Time frame	Description
Attendance at exercise classes	12 weeks	Attendance at exercise classes over the 12 week session will be analyzed across 'Lottery Insurance' and 'Standard Lottery' arms.

Secondary

Measure	Time frame	Description
Body Mass Index	Change from Baseline Body Mass Index at 12 weeks	Change from Baseline Body Mass Index (based on Centers for Disease Control calculations) at 12 weeks (post exercise session) will be assessed.
HbA1c	Change from Baseline HbA1c at 12 weeks	Change from Baseline glycemic control (measured as percentage glycosylated hemoglobin \[HbA1c\] as part of a fasting blood sample) at 12 weeks (post exercise session) will be assessed.
Blood Pressure	Change from Baseline Blood Pressure at 12 weeks	Change from Baseline Blood Pressure at 12 weeks (post exercise session) will be assessed.
LDL cholesterol	Change from Baseline LDL at 12 weeks	Change from Baseline LDL cholesterol (measured as part of a lipid panel) at 12 weeks (post exercise session) will be assessed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026